Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14Lung Neoplasms 8Prostatic Neoplasms 6Colorectal Neoplasms 6Neoplasms 5Pancreatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Smoking Cessation 2Skin Carcinoma 2Pain 2Melanoma 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Smoking 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Smoking 1Signs and Symptoms 1Sepsis 1Rectal Neoplasms 1Psoriasis 1

Interventions

Transcranial Direct Current Stimulation 1Tobacco Use Cessation Devices 1Tobacco Products 1Tablets 1Standard of Care 1Radiotherapy 1Mindfulness 1Methods 1Chemoradiotherapy 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking × Methods × 90 days × Clear all
NCT06945120 2026-03-13

ACT Lung Health Intervention: Phase Two

Dana-Farber Cancer Institute

Phase NA Recruiting
50 enrolled

Cigarette Smoking, Tobacco Smoking, Smoking, Smoking Cessation, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡